HLB group stocks mostly closed higher on the 31st, the last trading day of July, drawing attention to their price direction on the first trading day of August.

As of the market close on the 31st, HLB finished trading at 30,450 won, up 1.66% from the previous day. It defended the 30,000-won level at the close, extending its rebound trend.

Affiliates also showed overall strength. HLB Pharmaceutical closed up 2.52% at 8,130 won, and HLB Life Science finished up 4.93% at 2,020 won. In particular, HLB Innovation surged 9.49% to 8,300 won, and HLB Therapeutics also posted a notable gain of 9.01% to 1,657 won.

In addition, HLB Global closed up 6.06% at 1,241 won and HLB Panagen finished up 3.30% at 1,032 won, with most major group stocks rising in tandem.

The market analysis suggests that on the 31st, as the domestic stock market showed a strong upward trend led by semiconductor and large-cap tech stocks, investor sentiment in the biotech sector partially improved, leading to the broad rally in group stocks.

On the first trading day of August, the key focus will be whether HLB and other group stocks can sustain the rebound trend established on the final day of July, or if short-term profit-taking sell-offs will emerge. Attention is also expected to focus on external variables such as global market trends and geopolitical risks.

[※ This article is provided as reference material for investment decisions and does not recommend buying or selling any specific stock. The final responsibility for investment decisions lies with the investor.]